Skip to NavigationSkip to content

Novartis' Jonathan Peacock moves to Amgen

Published on: 23/07/10

Amgen has appointed Jonathan Peacock executive VP and chief financial officer with effect from 1 September.

He will move to the company from Novartis, where he has served as chief financial officer and administration officer since 2005.

Prior to that Jonathan was a partner at McKinsey and Company, where he was co-leader of the European corporate finance practice, and he has also been a partner at Price Waterhouse.

At Amgen he takes over from Michael Kelly, who has been serving as acting chief financial officer since May 2010.

In his new role Jonathan will be responsible for Amgen's finance and investor relations operations, reporting chairman and chief executive Kevin Sharer.

"I am delighted to have a leader of Jonathan's talent, vision and international experience join Amgen at a time when we are expanding globally," Sharer said.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches